Full Text View
Tabular View
No Study Results Posted
Related Studies
Study of Motavizumab (MEDI-524) and Palivizumab in the Same Respiratory Syncytial Virus (RSV) Season
This study has been completed.
Study NCT00316264   Information provided by MedImmune LLC
First Received: April 18, 2006   Last Updated: July 17, 2007   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Chronic Lung Disease
Additional conditions recognized in this trial
Infection
Lung Diseases
Respiratory Syncytial Virus Infections
Virus Diseases
More general conditions related to this trial
Mononegavirales Infections
Paramyxoviridae Infections
Pneumovirus Infections
Respiratory Tract Diseases
RNA Virus Infections
Interventions listed in this trial
MEDI-524
Additional drug interventions recognized in this trial
Palivizumab
More general drug interventions related to this trial
Anti-Infective Agents
Antiviral Agents
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
MedImmune LLC


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services